MingMed Biotech
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
MingMed Biotechnology is a clinical-stage company dedicated to the in-house discovery of novel drugs that address global unmet medical needs. We have built a product portfolio in four major therapeutic areas, namely ophthalmology, recombinant botulinum toxin, immuno-oncology and animal health care. Our product pipelines include a number of first-in-class drug candidates in Phase II or later clinical stage.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}